COVID-19: DCGI gives nod to anti-COVID drug developed by DRDO
The Drugs Controller General of India approved the drug 2-deoxy-D-glucose (2-DG) which is developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO in collaboration with Dr. Reddy’s Lab.
May 08, 2021, 17:04 PM IST
